VEGFA and gestational diabetes: In mouse and in vitro models, placental miR-195-5p targeted vascular endothelial growth factor A (VEGFA) in placental cells (54), and was an enhancer of zeste homolog 2 (EZH2) in umbilical cells (54), both of which may contribute to endothelial cell dysfunction and GDM progression.